Atlas Lithium Corporation — Q2 2023 Form 10-Q
Reporting period: Three and six months ended June 30, 2023; filed August 14, 2023. Atlas is a Brazil-focused mineral exploration and development company, principally advancing hard-rock lithium projects in Minas Gerais. It had not generated material product revenue.
Financial results and liquidity
| Metric | Q2 2023 | Q2 2022 | Six months 2023 | Six months 2022 |
|---|---|---|---|---|
| Revenue | $0 | $2,367 | $0 | $2,844 |
| Operating expenses | $9.524 million | $0.989 million | $14.003 million | $1.817 million |
| Net loss attributable to Atlas stockholders | $9.127 million | $0.871 million | $13.093 million | $1.403 million |
| Loss per share | $1.02 | $0.20 | $1.46 | $0.32 |
| Operating cash flow | Not presented by quarter | Not presented by quarter | $11.783 million | $(1.327) million |
Gross profit margin is not meaningful because 2023 revenue was zero; the company recorded no 2023 cost of revenue. Consolidated net loss, including non-controlling interests, was $9.397 million for Q2 and $13.862 million for the six-month period. Stock-based compensation was $2.852 million in Q2 and $3.981 million for the six months.
At June 30, cash and cash equivalents were $20.165 million, working capital was $16.640 million, and total assets were $28.129 million. Current liabilities were $3.612 million; total liabilities were $23.664 million, including $20 million of deferred consideration associated with the royalty transaction. The balance sheet reports no interest-bearing debt. Management said cash on hand was expected to meet working capital and capital expenditure needs for at least 12 months, through March 2024.
Changes, financing, and unusual items
- Losses increased substantially from 2022, driven by higher exploration spending, general and administrative costs, compensation, and stock-based compensation. Six-month exploration expense rose to $5.692 million from $20,421.
- On May 2, Atlas received $20 million for selling a 3% gross-revenue royalty on specified Brazilian properties. The royalty is payable quarterly once sales proceeds begin; LRC also received an option to buy an additional royalty for $5 million. The $20 million is reflected as deferred consideration, and its inclusion contributed significantly to reported operating cash flow. Thus, six-month operating cash flow should not be viewed as recurring operating cash generation.
- Six-month investing cash use was $2.680 million, mainly for mineral rights and capital assets. Financing provided $10.675 million, including proceeds from a January public offering and February private placement. The company also reported $1.676 million in gross proceeds from shares sold to Triton.
- After quarter-end, Atlas raised approximately $10 million gross from a July 18 private placement of 526,317 shares at $19 each; proceeds were intended for general working capital.
- Common shares outstanding were 10,033,334 at June 30 and 10,662,060 at August 14. The filing also describes a corrected 1-for-750 reverse split and changes to authorized share capital.
Operations, outlook, and risks
- Atlas reported 10 active drills and 33,664 meters drilled at Neves as of June 30, with drilling at approximately 7,400 meters per month. A maiden mineral resource report was expected in Q3 2023; that expectation is not a guarantee of completion or resource size.
- The company reported metallurgical test results of 6.04% Li2O concentrate, 0.53% Fe2O3, and 70% lithium recovery from a representative sample. These are test results, not commercial production results.
- A non-binding, non-exclusive MOU with Mitsui contemplated up to $65 million of milestone-based funding and potential offtake rights for up to 100% of production from a proposed 150,000-ton-per-year plant. The filing also describes separate initial planning for a 300,000-ton-per-year processing facility. Neither facility nor funding was assured.
- Management cautioned that further financing may be needed; if unavailable or unfavorable, Atlas could reduce operations or growth plans. Key risks include exploration and resource-estimation uncertainty, permitting and regulatory delays, commodity prices and demand, currency movements, project financing, and the ability to develop and operate processing facilities.
- The filing reported no material legal proceedings and no material changes to previously disclosed risk factors. Management concluded disclosure controls were effective at a reasonable assurance level and reported no material internal-control changes during the quarter.
Important facts for investors to verify
- Whether the expected Q3 maiden resource report was completed and what independently supported resource estimate it established.
- How the $20 million royalty proceeds are being used, the precise properties covered, and the long-term cost of the 3% royalty and additional-royalty option.
- Whether Mitsui discussions progressed to binding financing or offtake agreements, and which proposed plant capacity is being pursued.
- Current cash, spending pace, financing runway, and any additional equity issuance or dilution after the July placement.
- Whether reported drilling and metallurgical results support an economically viable project; exploration results and laboratory tests alone do not establish commercial reserves or production economics.